PELI3
Basic information
Region (hg38): 11:66466327-66477337
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PELI3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 21 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 21 | 0 | 0 |
Variants in PELI3
This is a list of pathogenic ClinVar variants found in the PELI3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-66468160-C-T | not specified | Uncertain significance (Aug 09, 2021) | ||
11-66468219-C-G | not specified | Uncertain significance (Feb 16, 2023) | ||
11-66468222-G-A | not specified | Uncertain significance (Mar 29, 2023) | ||
11-66468228-G-A | not specified | Uncertain significance (May 30, 2024) | ||
11-66471280-G-A | not specified | Uncertain significance (Apr 08, 2022) | ||
11-66472375-A-C | not specified | Uncertain significance (Jun 11, 2021) | ||
11-66472424-C-T | not specified | Uncertain significance (Aug 17, 2022) | ||
11-66472453-G-A | not specified | Uncertain significance (Sep 28, 2022) | ||
11-66473248-G-A | not specified | Uncertain significance (Jun 13, 2024) | ||
11-66473287-C-T | not specified | Uncertain significance (Nov 19, 2022) | ||
11-66473290-C-G | not specified | Uncertain significance (May 05, 2023) | ||
11-66473307-G-A | not specified | Uncertain significance (Aug 30, 2022) | ||
11-66473310-G-A | not specified | Uncertain significance (Nov 21, 2022) | ||
11-66473371-G-A | not specified | Uncertain significance (Apr 27, 2023) | ||
11-66473380-A-G | not specified | Uncertain significance (Jun 01, 2023) | ||
11-66473855-G-A | not specified | Uncertain significance (Apr 24, 2024) | ||
11-66473870-G-T | not specified | Uncertain significance (Aug 31, 2022) | ||
11-66473915-G-A | not specified | Uncertain significance (Jun 05, 2024) | ||
11-66475667-C-T | not specified | Uncertain significance (Dec 30, 2023) | ||
11-66475722-G-A | not specified | Uncertain significance (Jan 02, 2024) | ||
11-66475806-C-T | not specified | Uncertain significance (Mar 01, 2024) | ||
11-66475815-A-T | not specified | Uncertain significance (Jun 11, 2021) | ||
11-66475905-A-T | not specified | Uncertain significance (Jan 20, 2023) | ||
11-66476153-G-C | not specified | Uncertain significance (Jun 28, 2023) | ||
11-66476157-C-T | not specified | Uncertain significance (Aug 16, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PELI3 | protein_coding | protein_coding | ENST00000320740 | 7 | 10593 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00949 | 0.988 | 125724 | 0 | 24 | 125748 | 0.0000954 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.43 | 200 | 323 | 0.620 | 0.0000226 | 2968 |
Missense in Polyphen | 107 | 184.25 | 0.58074 | 1722 | ||
Synonymous | 0.769 | 132 | 144 | 0.918 | 0.0000106 | 1023 |
Loss of Function | 2.69 | 7 | 20.0 | 0.350 | 0.00000110 | 203 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000585 | 0.0000585 |
Ashkenazi Jewish | 0.0000995 | 0.0000992 |
East Asian | 0.000228 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000566 | 0.0000527 |
Middle Eastern | 0.000228 | 0.000217 |
South Asian | 0.000372 | 0.000359 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin ligase catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins. Involved in the TLR and IL-1 signaling pathways via interaction with the complex containing IRAK kinases and TRAF6. Mediates 'Lys-63'-linked polyubiquitination of IRAK1. Can activate AP1/JUN and ELK1. Not required for NF-kappa-B activation. {ECO:0000269|PubMed:12874243, ECO:0000269|PubMed:17675297}.;
- Pathway
- Regulation of toll-like receptor signaling pathway;Toll Like Receptor 7/8 (TLR7/8) Cascade;Signaling by Interleukins;Cytokine Signaling in Immune system;Toll Like Receptor 9 (TLR9) Cascade;MyD88 cascade initiated on plasma membrane;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll-Like Receptors Cascades;Interleukin-1 signaling;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;Innate Immune System;Immune System;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;Toll Like Receptor 4 (TLR4) Cascade;IRAK1 recruits IKK complex;MyD88:Mal cascade initiated on plasma membrane;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll Like Receptor 2 (TLR2) Cascade;Interleukin-1 family signaling
(Consensus)
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- loftool
- 0.525
- rvis_EVS
- 0
- rvis_percentile_EVS
- 53.73
Haploinsufficiency Scores
- pHI
- 0.322
- hipred
- Y
- hipred_score
- 0.568
- ghis
- 0.521
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.675
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Peli3
- Phenotype
- immune system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype;
Gene ontology
- Biological process
- protein polyubiquitination;protein phosphorylation;Toll signaling pathway;negative regulation of tumor necrosis factor-mediated signaling pathway;interleukin-1-mediated signaling pathway;protein K63-linked ubiquitination;negative regulation of extrinsic apoptotic signaling pathway
- Cellular component
- cytosol
- Molecular function
- protein serine/threonine kinase activity;protein binding;ubiquitin protein ligase activity